FDA approves new drug for MAS in Still's disease. Gamifant (emapalumab-lzsg) is interferon gamma (IFNγ)–blocking Ab approved For HLH, now for use in adults & children w/ Still's Dz complicated by Macrophage Activation Syndrome. https://t.co/3div1fktWU https://t.co/VvSkuEoki5
Links:
FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and…
https://buff.ly/5XZFFOD
Jul-01-2025
